Lv61
2020 积分 2021-11-03 加入
Efficacy and safety of once-weekly semaglutide 2·4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial
7小时前
已完结
Efficacy and safety of once-weekly semaglutide 2·4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial
7小时前
已完结
Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study
3天前
已完结
The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study
3天前
已完结
Long-term effects and effect heterogeneity of lifestyle and metformin interventions on type 2 diabetes incidence over 21 years in the US Diabetes Prevention Program randomised clinical trial
14天前
已完结
Safety and effectiveness of metformin plus lifestyle intervention compared with lifestyle intervention alone in preventing progression to diabetes in a Chinese population with impaired glucose regulation: a multicentre, open-label, randomised controlled trial
14天前
已完结
Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
1个月前
已完结
肠促胰素类药物在2型糖尿病患者血脂谱和脂肪分布中的调节作用
1个月前
已完结
Predictors of suboptimal glycaemic control in type 2 diabetes patients: the role of medication adherence and body mass index in the relationship between glycaemia and age
1个月前
已完结
Prediabetes remission for type 2 diabetes mellitus prevention
2个月前
已完结
皖公网安备34019202002308
